Blood · 2001 · 132 citations · 13 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyOncology PharmacotherapyHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyReceptor Tyrosine Kinase SignalingRelapsed DiseaseTyrosine Kinase InhibitorsAcute LeukemiasAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentRefractory Acute Myeloid LeukemiaRefractory LeukemiaTyrosine Kinase Inhibitor Therapy
The small molecule receptor tyrosine kinase (RTK) inhibitor SU5416 targets the vascular endothelial growth factor receptor 2 and the stem cell factor receptor c-kit. Herein is described the successful treatment of a 65-year-old woman with SU5416, in second relapse of acute myeloid leukemia (AML) and refractory toward standard chemotherapy regimens. After 12 weeks of treatment with SU5416, the blast cell counts (blood and bone marrow) decreased to undetectable levels and the peripheral blood cell counts normalized with the exception of the platelet count (50-80 x 10(9)/L [50-80 x 10(3)/microL]). The duration of the remission is longer than 4 months during maintenance therapy with SU5416. Microvessel density in the patient's bone marrow dropped from 33.4 to 12.3 microvessels/x500-field 8 weeks after SU5416 administration and remains in the normal range. This is the first report of a stable remission achieved after administration of the RTK inhibitor SU5416 in a patient with AML relapse.
13
Induction of angiogenesis during the transition from hyperplasia to neoplasia
J Folkman, Karol Watson, Donald E. Ingber et al. · Nature · 1989 · 1.9K citations
Medicine, Cell Biology, Oncology +10
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
B Millauer, Laura K. Shawver, Karl H. Plate et al. · Nature · 1994 · 1.2K citations
Medicine, Cancer Biology, Oncology +12
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
William Bellamy, L Richter, Y Frutiger et al. · PubMed · 1999 · 531 citations
Medicine, Hematology, Oncology +15
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
Teresa Padró, Sandra Ruíz, Ralf Bieker et al. · Blood · 2000 · 471 citations
Medicine, Hematology, Oncology +14